Objective-Proatherosclerotic adhesion of leukocytes to the endothelium is attenuated by NO. As AMP-activated protein kinase (AMPK) regulates endothelial NO synthesis, we investigated the modulation of adhesion to cultured human aortic endothelial cells (HAECs) by AMPK. Methods and Results-HAECs incubated with the AMPK activator, AICAR, or expressing constitutively active AMPK demonstrated reduced TNF␣-stimulated adhesion of promonocytic U-937 cells. Rapid inhibition of TNF␣-stimulated U-937 cell adhesion by AICAR was NO-dependent, associated with unaltered cell surface adhesion molecule expression, and reduced MCP-1 secretion by HAECs. In contrast, inhibition of TNF␣-stimulated U-937 cell adhesion by prolonged AMPK activation was NO-independent and associated with reduced cell surface adhesion molecule expression. Conclusions-AMPK activation in HAECs inhibits TNF␣-stimulated leukocyte adhesion by a rapid NO-dependent mechanism associated with reduced MCP-1 secretion and a late NO-independent mechanism whereby adhesion molecule expression, in particular E-selectin, is suppressed. (Arterioscler Thromb Vasc Biol. 2008;28:000-000.)
R ecent studies have demonstrated AMPK-activated protein kinase (AMPK) to be a key regulator of NO synthesis in cultured endothelial cells in response to stimuli including AICAR. 1, 2 The functional effects of AMPKmediated NO production in the endothelium remain poorly characterized, however. Endothelial NO inhibits leukocyte adhesion and the expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule (VCAM)-1, and E-selectin in response to proinflammatory stimuli such as TNF␣. 3 AICAR has recently been reported to reduce TNF␣-stimulated monocyte adhesion and mRNA expression of ICAM-1, VCAM-1, and E-selectin in cultured endothelial cells and postischemic leukocyte rolling and adhesion in mice. 4, 5 However, these studies did not address whether the effects of AICAR are mediated by NO or AMPK, as AICAR has been demonstrated to have AMPKindependent effects. 6 We have, therefore, investigated the molecular mechanisms that underlie reduced monocyte adhesion in response to AICAR.
Methods

Cell Systems and Infection
HAECs, cultured as described previously, 2 were infected with recombinant adenoviruses expressing constitutively active (Ad.AMPK-CA) mutant AMPK, dominant negative (Ad.AMPK-DN) mutant AMPK, or control adenoviruses (Ad.control) as described previously. 2 
Monocyte Adhesion and Chemokine Secretion Assay
To ensure that observed effects of AMPK activation were specific to HAECs, HAEC monolayers were washed thoroughly with serumfree medium before overlay with U-937 cells or chemokine assay. Adhesion was assessed microscopically and chemokine secretion by immunoassay.
Flow Cytometry
Cell surface E-Selectin, ICAM-1, and VCAM-1 expression were quantified using anti-VCAM-1, anti-ICAM-1, or anti-E-Selectin antibodies and fluorescein isothiocyanate (FITC)-or phycoerythrinlabeled secondary antibodies.
For details, see the supplemental materials (available online at http://atvb.ahajournals.org).
Results
Incubation of HAECs with AICAR reduced TNF␣-stimulated U-937 cell adhesion in a time-and dose-dependent manner without affecting basal U-937 cell adhesion (Figure 1A and 1C; supplemental Figure I ) or HAEC viability as assessed by Annexin V staining (data not shown). Infection with Ad.AMPK-CA completely abrogated TNF␣-stimulated U-937 cell adhesion, without altering basal adhesion ( Figure  1B) . Preincubation of HAECs with the eNOS inhibitor, L-NAME, abrogated the rapid (45 to 90 minutes) inhibition of TNF␣-stimulated U-937 cell adhesion by AICAR, but had no effect on inhibition of adhesion in response to long term (120 to 360 minutes) AICAR treatment or Ad.AMPK-CA ( Figure 1A and 1B). Similar effects were observed after siRNA-mediated downregulation of eNOS (supplemental Figure II) . Infection with Ad.AMPK-DN attenuated AMPK activity (supplemental Figure III) and the inhibition of TNF␣-stimulated U-937 cell adhesion by AICAR ( Figure 1C) .
Incubation of HAECs with AICAR (240 minutes) or infection with Ad.AMPK-CA inhibited TNF␣-stimulated cell surface expression of ICAM-1, VCAM-1, and E-selectin, yet incubation with AICAR for 45 minutes did not affect adhesion molecule expression (Figure 2A) . Infection with Ad.AMPK-DN reversed AICAR-mediated inhibition of E-selectin expression ( Figure 2B ) and partially reversed inhibition of ICAM-1 and VCAM-1 expression (supplemental Figure IV ). L-NAME did not affect expression of adhesion molecules ( Figure 2B and supplemental Figure IV) .
As acute incubation with AICAR reduced U-937 cell adhesion independent of HAEC adhesion molecule expression, we reasoned AICAR may inhibit chemokine secretion by HAECs. Incubation of HAECs with AICAR for 45 minutes significantly reduced TNF␣-stimulated MCP-1 secretion, an effect partially abrogated by coincubation of HAECs with L-NAME ( Figure 2C ) or infection with Ad.AMPK-DN ( Figure 2D ).
Discussion
The central finding of this study is that incubation of HAECs with AICAR markedly reduces TNF␣-stimulated monocyte adhesion in a biphasic and AMPK-dependent manner. These data suggest that the rapid adhesion molecule-independent effects of AICAR are mediated by AMPK-stimulated NO synthesis reducing secretion of MCP-1 and potentially secretion of other chemokines by HAECs in response to TNF␣. Prolonged incubation with AICAR reduces TNF␣-stimulated E-selectin expression in an AMPK-dependent NOindependent manner, whereas AICAR reduces TNF␣-stimulated ICAM-1 and VCAM-1 expression by a mechanism only partially dependent on AMPK. A recent study reported that AICAR reduced postischemic leukocyte adhesion in an eNOS-independent manner, yet leukocyte rolling in response to prolonged AICAR treatment was eNOSdependent. 5 The differences between the current study and these data may reflect the different species studied and lack of assessment of the AMPK-dependence and site of action of AICAR in vivo.
The evidence presented in this study clearly implicates AMPK activation as a potential antiatherogenic mechanism. Atherosclerosis is commonly associated with type 2 diabetes and insulin resistance, and we propose that AMPK, in addition to its potential to correct the metabolic defects present in type 2 diabetes and insulin resistance, 7 is an attractive candidate therapeutic target for reducing associated atherogenesis. 
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SUPPLEMENTARY MATERIALS AND METHODS
Materials
Oligofectamine w as supplied by Invitrogen Ltd ( Paisley, Renfrewshire, UK).
Mouse anti-VCAM-1, mouse anti-ICAM-1, FITC-and phycoerythrin-labeled anti-mouse antibodies were obtained from Abcam (Cambridge, UK). Mouse anti-E-selectin antibodies were obtained from Serotec (Oxford, UK). Dharmacon ON-TARGETplus SMARTpool siRNA targeted to eNOS, GAPDH and scrambled control siRNA were obtained from Thermo Fisher Scientific Biosciences UK (Cramlington, Northumberland, UK). All other reagents were from sources described previously [1] [2] [3] .
Cell Culture and recombinant AMPK adenoviruses
HAEC and U-937 cells were cultured as described previously [1, 2] . HAECs were infected with 20-80 pfu/cell recombinant adenoviruses expressing constitutively active (Ad.AMPK-CA) mutant AMPK, dominant negative (Ad.AMPK-DN) mutant AMPK or control adenoviruses (Ad.control: adenoviruses expressing GFP alone for experiments with Ad.AMPK-CA or lacking any exogenous gene for experiments with Ad.AMPK-DN), propagated and purified as described previously [1, 2, 4 ] .
Transfection of HAECs with siRNA
Serum-free endothelial cell culture medium (300 µl) containing 0.25% (v/v) oligofectamine and 0.17 µM siRNA was added to each well of HAECs grown to near confluence on 24-well tissue culture plates. After 5 h, 250 µl of large vessel endothelial cell medium was added. After 24 h, medium was removed and the transfection procedure repeated. After a further 24 h, cell lysates were prepared or U-937 adhesion assessed.
Preparation of HAEC lysates
HAEC lysates were prepared and proteins resolved by SDS-PAGE and western blotting as described previously [1] [2] [3] .
Monocyte Adhesion Assay
HAECs were infected with recombinant AMPK adenoviruses or transfected with siRNA, if desired, for 24 h or 48 h respectively prior to adhesion assay. Adhesion of U-937 cells was assessed as described previously [ 2] . As HAEC monolayers were washed thoroughly with serum -free medium prior to overlay with U-937 cells , the U-937 cells are not exposed to adenoviruses, TNFα, L-NAME or AICAR using this protocol, ensuring that observed effects are HAEC-mediated and not a result of altered U-937 function.
Flow cytometry for cell surface VCAM, ICAM and E-Selectin expression
HAECs were grown to confluence on 12-well tissue culture plates and infected 
Analysis of conditioned medium from HAECs for chemotactic potential
Conditioned medium was obtained from HAECs incubated for 1h as described for monocyte adhesion analysis (after thorough washing to remove any adenoviruses, TNFα, AICAR or L-NAME). Migration of U-937 cells was determined using a 48-well 
Statistical analysis
Unless stated otherwise, results are expressed as the means ± S.D. Statistically significant differences were determined using an independent-samples Student's t test, with p < 0.05 as significant.
SUPPLEMENTARY RESULTS
Dose-dependence of AICAR-mediated inhibition of U-937 cell adhesion to HAECs.
Incubation of HAECs with AICAR for 45 min significantly inhibited TNFα-stimulated U-937 cell adhesion at a concentration of 0.5 mM and was maximally effective at a concentration of 2 mM (Supplemental Figure I) .
NO-dependence of AICAR-mediated inhibition of U-937 cell adhesion to HAECs.
As demonstrated in Figure 1A , preincubation of HAECs with L-NAME abrogated the rapid inhibition of TNFα-stimulated U-937 cell adhesion by 45-90 min incubation with AICAR, but had no effect on inhibition of TNFα-stimulated adhesion in response to long term AICAR treatment (120-360 min). To support the temporal nature of this NOdependent action of AICAR, we used siRNA targeted to eNOS to downregulate eNOS.
Transfection of HAECs with siRNA targeted to eNOS significantly downregulated eNOS
protein expression compared to scrambled control siRNA and attenuated the rapid inhibition of TNFα-stimulated adhesion in response to AICAR (Supplemental Figure II) .
Transfection with siRNA targeted to eNOS was without effect on either unstimulated U-937 cell adhesion or inhibition of TNFα-stimulated adhesion in response to long term AICAR treatment.
AMPK-dependence of AICAR-mediated inhibition of U-937 cell adhesion to HAECs.
To ensure that downregulation of AMPK activity occurred upon infection with
Ad.AMPK-DN, phosphorylation of the AMPK substrate, acetyl-CoA carboxylase (ACC)
was assessed by western blotting of cell lysates. As described previously, infection of
HAECs with Ad.AMPK-DN prevented AICAR-stimulated phosphorylation of the AMPK substrate ACC (Supplemental Figure III) [ 1, 3] . Infection with Ad.AMPK-DN had no effect on basal U -937 cell adhesion compared to cells infected with control adenoviruses ( Figure 1C ).
Effect of AICAR on adhesion molecule expression.
TNFα 
Effect of AICAR on U-937 cell chemotaxis and HAEC chemokine secretion.
As acute incubation with AICAR altered U -937 cell adhesion independent of HAEC adhesion molecule expression, we initially determined whether migration of U-937 cells was reduced towards conditioned media from AICAR-treated HAECs. In these experiments, conditioned media was collected from HAECs subsequent to infection with Ad.control or Ad.AMPK-DN and stimulation in the presence or absence of TNFα and/or L-NAME for 6 h and AICAR for 45 min. Since the HAECs were thoroughly washed to remove TNFα, L -NAME and AICAR prior to collection of conditioned medium, these had no effect on migration directly. U-937 cell migration was increased towards conditioned media from TNFα-stimulated HAECs ( Supplemental Figure V) . Lysates were prepared from HAECs infected with the adenoviruses indicated after incubation in the presence or absence of 2mM AICAR for 45min and subjected to western blotting using anti-ACC and anti-phospho-ACC antibodies. Representative immunoblots are shown.
